The initial reporter received questionable reproducible elecsys ft4 iii assay results for one patient from elecsys 2010 disk analyzer serial number (b)(4).The customer suspected interference as the results do not fit the clinical picture in a patient with multiple sclerosis under treatment with the immunoregulating drug coparaxon 40 (glatiramer).The ft4 results were 2.28 ng/dl and 2.26 ng/dl.Information was requested if any questionable result was reported outside of the laboratory, but it was not known.
|